Cambricon(SH:688256) 第一财经·2025-08-21 02:12Core Viewpoint - The stock price of Cambrian Biologics has risen over 4% on August 21, reaching a historical high and a market capitalization of 440 billion CNY [1]. Group 1: Stock Performance - Cambrian Biologics' stock price increased by 7.06% with a trading volume of 6.359 billion CNY [2]. - The stock opened at 1020.00 CNY, with a highest price of 1066.00 CNY and a lowest price of 1005.57 CNY, resulting in a trading amplitude of 5.97% [2]. - The total market value of Cambrian Biologics is reported to be 441.4 billion CNY, with a circulating market value of 441.4 billion CNY [2]. Group 2: Financial Metrics - The earnings per share (EPS) for Cambrian Biologics is 0.31, with an estimated EPS of 3.87 for 2025 [2]. - The total share capital is 418 million shares, with a free float of 203 million shares [2]. - The price-to-earnings ratio (P/E) is reported at 3400, while the price-to-book ratio (P/B) stands at 74.87 [2].